…
Scientific Industries, Inc. engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally. The company offers laboratory vortex mixers, shakers, and accessories; rotators and rockers accessories; disruptors and shakers accessories; as well as incubators under the Genie brand name. It also provides pharmacy, laboratory, industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gauges, and test stands products under the Torbal brand; and bioprocessing systems comprising cell growth quantifier for biomass monitoring in shake flasks; liquid injection systems for automated feeding in shake flasks; various coaster systems and flow-through cells for pH and DO monitoring and analytical software; and multi-parameter sensor and dissolved oxygen sensor pills. The company's products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industries performing laboratory-scale research. It sells its products through laboratory equipment distributors and end users through e-commerce. Scientific Industries, Inc. was incorporated in 1954 and is headquartered in Bohemia, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Scientific Industries Inc. is a small, U.S.-based manufacturer and distributor of laboratory instruments and related consumables serving research, clinical and industrial laboratories. Long-term growth may be supported by rising global spending on life-sciences research, diagnostics and laboratory capacity expansion, and by recurring aftermarket and service sales. Investors may find the company attractive for its niche product exposure to steady laboratory equipment demand.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-06-30 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-06-30 | 2021-12-31 |
| Income before tax | -1.78M | -8.02M | -9.09M | -7.00M | -7.00M |
| Net income | -1.22M | -6.45M | -9.09M | -5.64M | -5.64M |
| Selling general administrative | 6.41M | 7.33M | 10.80M | 10.13M | 10.13M |
| Gross profit | 1.30M | 2.01M | 5.10M | 5.74M | 5.74M |
| Reconciled depreciation | 0.61M | 0.75M | 0.75M | 0.69M | 0.69M |
| Ebit | - | - | - | -7.26M | -7.26M |
| Ebitda | - | - | - | -6.58M | -6.58M |
| Operating income | -7.60M | -8.22M | -9.26M | -7.26M | -7.26M |
| Tax provision | 0.00M | 0.00M | 0.00M | -1.35M | -1.35M |
| Interest income | 0.14M | 0.18M | 0.11M | 0.08M | 0.08M |
| Net interest income | 0.14M | 0.18M | 0.11M | 0.08M | 0.08M |
| Income tax expense | - | - | - | -1.35M | -1.35M |
| Total revenue | 5.05M | 4.80M | 11.11M | 11.40M | 11.40M |
| Total operating expenses | 12.65M | 13.01M | 20.37M | 18.66M | 18.66M |
| Cost of revenue | 3.75M | 2.79M | 6.01M | 5.66M | 5.66M |
| Total other income expense net | 5.68M | 0.01M | 0.06M | 0.19M | 0.19M |
| Discontinued operations | - | - | - | 0.00M | 0.00M |
| Net income from continuing ops | -1.78M | -8.02M | -9.09M | -5.65M | -5.65M |
| Net income applicable to common shares | - | - | - | -5.64M | -5.64M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-06-30 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-06-30 | 2021-12-31 |
| Total assets | 12.61M | 11.56M | 16.73M | 29.03M | 29.03M |
| Intangible assets | 0.10M | 0.75M | 1.25M | 2.08M | 2.08M |
| Other current assets | 1.12M | 0.32M | 0.41M | 0.00M | 0.00M |
| Total liab | 1.94M | 2.44M | 2.85M | 3.47M | 3.47M |
| Total stockholder equity | 10.66M | 9.12M | 13.89M | 25.56M | 25.56M |
| Other current liab | 0.01M | 0.46M | - | 0.03M | 0.03M |
| Common stock | - | - | - | 0.35M | 0.35M |
| Capital stock | 0.60M | 0.53M | 0.51M | 0.35M | 0.35M |
| Retained earnings | -35.15M | -33.93M | -27.49M | -6.30M | -6.30M |
| Good will | 0.12M | 0.12M | 0.12M | 4.40M | 4.40M |
| Other assets | - | - | - | 3.81M | 3.81M |
| Cash | 0.95M | 0.59M | 0.80M | 2.97M | 2.97M |
| Total current liabilities | 1.35M | 1.75M | 1.84M | 2.23M | 2.23M |
| Other stockholder equity | - | - | - | -0.11M | -0.11M |
| Property plant equipment | - | - | - | 2.48M | 2.48M |
| Total current assets | 10.39M | 8.29M | 12.34M | 16.27M | 16.27M |
| Net tangible assets | - | - | - | 19.09M | 19.09M |
| Short term investments | 5.71M | 1.99M | 4.93M | 6.39M | 6.39M |
| Net receivables | 0.87M | 0.58M | 1.16M | 1.66M | 1.50M |
| Inventory | 1.40M | 2.06M | 4.88M | 4.70M | 4.70M |
| Accounts payable | 0.45M | 0.28M | 0.71M | 1.11M | 1.11M |
| Non currrent assets other | 0.39M | 0.67M | 0.67M | 0.06M | 0.06M |
| Non current assets total | 2.22M | 3.27M | 4.39M | 12.76M | 12.76M |
| Capital lease obligations | 0.97M | 1.00M | 1.33M | 1.54M | 1.54M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-06-30 |
| Investments | -3.72M | 2.96M | -0.60M | - | -2.92M |
| Change to liabilities | - | - | - | - | 0.68M |
| Total cashflows from investing activities | - | - | - | - | -3.75M |
| Net borrowings | - | - | 0.00M | - | - |
| Total cash from financing activities | 1.95M | 0.65M | 5.75M | - | 2.63M |
| Change to operating activities | - | - | - | - | -0.37M |
| Net income | -1.22M | -6.45M | -9.09M | -8.16M | -5.64M |
| Change in cash | -2.33M | 0.43M | -1.13M | - | -6.70M |
| Begin period cash flow | 0.59M | 0.80M | 1.93M | 2.97M | 9.68M |
| End period cash flow | 0.95M | 0.59M | 0.80M | 1.93M | 2.97M |
| Total cash from operating activities | -8.15M | -3.05M | -6.16M | - | -5.51M |
| Issuance of capital stock | 2.05M | 0.72M | 6.28M | - | 3.00M |
| Depreciation | 0.61M | 0.75M | 0.75M | - | 0.69M |
| Change to inventory | -0.68M | 2.48M | -0.01M | - | -1.72M |
| Change to account receivables | -0.29M | 0.58M | 0.12M | - | -0.21M |
| Sale purchase of stock | - | - | - | - | -0.27M |
| Other cashflows from financing activities | - | - | - | - | -0.37M |
| Change to netincome | - | - | - | - | 0.89M |
| Capital expenditures | 0.06M | 0.10M | 0.13M | 0.00M | 0.76M |
| Change in working capital | -2.02M | 2.39M | -0.28M | - | -1.44M |
| Stock based compensation | 0.52M | 1.17M | 2.24M | - | 2.35M |
| Other non cash items | -7.70M | 0.96M | 0.27M | - | -0.04M |
| Free cash flow | -8.21M | -3.15M | -6.29M | - | -6.34M |
Sector: Technology Industry: Scientific & Technical Instruments
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SCND Scientific Industries Inc |
- -% |
0.60 | - | - | 1.67 | 1.18 | 1.01 | -4.37 |
| KYCCF Keyence |
13.69 3.10% |
454.69 | 41.66 | 38.76 | 0.11 | 5.69 | 0.10 | 0.19 |
| COHR Coherent Corp |
5.51 2.71% |
208.94 | 333.78 | 46.73 | 10.24 | 7.63 | 10.78 | 62.92 |
| GRMN Garmin Ltd |
-1.57 0.56% |
278.10 | 28.91 | 24.45 | 7.01 | 5.99 | 6.72 | 22.32 |
| KEYS Keysight Technologies Inc |
1.31 0.46% |
286.94 | 42.58 | 20.00 | 8.11 | 8.16 | 8.17 | 28.06 |
Scientific Industries, Inc. engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally. The company offers laboratory vortex mixers, shakers, and accessories; rotators and rockers accessories; disruptors and shakers accessories; as well as incubators under the Genie brand name. It also provides pharmacy, laboratory, industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gauges, and test stands products under the Torbal brand; and bioprocessing systems comprising cell growth quantifier for biomass monitoring in shake flasks; liquid injection systems for automated feeding in shake flasks; various coaster systems and flow-through cells for pH and DO monitoring and analytical software; and multi-parameter sensor and dissolved oxygen sensor pills. The company's products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industries performing laboratory-scale research. It sells its products through laboratory equipment distributors and end users through e-commerce. Scientific Industries, Inc. was incorporated in 1954 and is headquartered in Bohemia, New York.
80 Orville Drive, Bohemia, NY, United States, 11716
631 567 4700
54
| Name | Title | Year Born |
|---|---|---|
| Ms. Helena R. Santos CPA | Pres, CEO, Compliance Officer, Treasurer & Director | 1964 |
| Mr. Daniel Greunes | Chief Exec. Officer of the Bioprocessing Operations | 1988 |
| Mr. Reginald Averilla | Chief Financial Officer | 1978 |
| Mr. Karl D. Nowosielski | Pres of Torbal Products Div. - Benchtop Laboratory Equipment Ops & Director of Marketing | 1979 |
| Mr. Robert P. Nichols | Pres of Genie Products Division - the Benchtop Laboratory Equipment Operations & Sec. | 1961 |
| Mr. Anthony J. Mitri | Pres of Altamira | 1982 |
| Ms. Helena R. Santos CPA | President, CEO, Treasurer, Director & Secretary | 1964 |
| Mr. Zachary Rovinsky CPA | Chief Financial Officer | 1968 |
| Mr. Karl D. Nowosielski | President of Torbal Products Division - Benchtop Laboratory Operations | 1979 |
| Mr. Daniel Donadille | CEO & President of the Bioprocessing Systems Operations | 1989 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.